Neurology· Topic 10.11 Multiple sclerosis and neuro-ophthalmic disorders· 10.11.5

MOG antibody-associated disease

MOG antibody-associated disease is an antibody-mediated inflammatory demyelinating disorder of the central nervous system, directed at myelin oligodendrocyte glycoprotein, that presents as optic neuritis, transverse myelitis, or acute disseminated encephalomyelitis and encephalitis, with a monophasic or recurrent, steroid-responsive course. It is confirmed by MOG antibody testing in a compatible syndrome, separated from multiple sclerosis by limited brain involvement, longitudinally extensive cord lesions, and marked CSF pleocytosis; attacks are treated with high-dose IV methylprednisolone and plasma exchange, and recurrent disease with long-term immunosuppression.

8 min read1 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Definition: MOG antibody-associated disease (MOGAD) is an antibody-mediated inflammatory demyelinating disorder of the central nervous system in which antibodies against myelin oligodendrocyte…

  • Epidemiology

    Less common than MS: MS remains the most common inflammatory demyelinating disease of the central nervous system, so MOGAD must be actively sought with antibody testing.

  • Risk factors

    Preceding infection: single-episode demyelinating events such as ADEM and transverse myelitis are often postinfectious, and most transverse myelitis follows a recent gastroenteritis or upper respiratory infection.

  • Pathophysiology

    Antibody-directed inflammation: antibodies against myelin oligodendrocyte glycoprotein trigger inflammatory demyelination, concentrated in the optic nerves and spinal cord.

  • Clinical features

    Optic neuritis: subacute loss of vision in one or both eyes over days, with pain on eye movement, reduced acuity, a scotoma, impaired color vision, and a relative afferent pupillary defect…

  • Differential diagnosis

    Spinal cord compression and spinal epidural abscess: compressive myelopathy with localized back pain and, in abscess, fever; urgent spine MRI excludes it before an inflammatory diagnosis is made; see spinal cord compression.

  • Diagnosis

    Basis of diagnosis: MOGAD is established by a positive MOG antibody test in a patient with a core inflammatory demyelinating syndrome (optic neuritis, transverse myelitis, or ADEM or encephalitis)…

  • Management

    First, start high-dose IV glucocorticoids for the acute attack: methylprednisolone 1 g IV once daily for 3-5 days (up to 7 days for myelitis); screen for infection, uncontrolled diabetes, and peptic ulcer disease before the pulse.

  • Complications

    Permanent visual loss: optic nerve atrophy, seen as a pale, flat disc weeks to months after optic neuritis, can leave fixed visual deficits.

  • Prognosis

    Steroid-responsive attacks: acute attacks generally respond to high-dose glucocorticoids, with plasma exchange for those that do not.

  • Prevention

    No primary prevention: prevention is directed at relapses and at avoiding harmful MS therapy.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.